Sarah Hutchinson
Physician Assistant · Shreveport, LANPI 1770866139
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.4% of the total across 646 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 33 manufacturers reported payments, led by GSK at 24.5% of the total. Among physician assistant clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 646 payments — averaging $18.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$3K
- AstraZeneca$2K
- Actelion Pharmaceuticals US, Inc.$2K
- Boehringer Ingelheim$978
- United Therapeutics Corporation$552
- Sanofi$438
- plus $3K from 27 others
What the payments were for
- Food & beverage$11,78996%
- Education$4454%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 171 | $2,997 |
| AstraZeneca(2 entities) | 106 | $2,315 |
| Actelion Pharmaceuticals US, Inc. | 113 | $1,606 |
| Boehringer Ingelheim | 51 | $978 |
| United Therapeutics Corporation | 25 | $552 |
| Sanofi | 19 | $438 |
| Johnson & Johnson(3 entities) | 19 | $366 |
| Amgen | 14 | $347 |
| Grifols USA, LLC | 14 | $326 |
| Regeneron Healthcare Solutions, Inc. | 11 | $253 |
| Baxter Healthcare | 14 | $251 |
| Mallinckrodt Hospital Products Inc. | 11 | $243 |
| Mylan Specialty L.p. | 10 | $185 |
| Verona Pharma, Inc. | 10 | $182 |
| Merck | 7 | $154 |
| Advanced Respiratory, Inc | 9 | $152 |
| Revance Therapeutics, Inc. | 2 | $145 |
| Insmed, Inc. | 6 | $137 |
| Paratek Pharmaceuticals, Inc. | 5 | $100 |
| Electromed, Inc. | 4 | $69 |
| Bayer | 4 | $66 |
| Shionogi Inc | 4 | $64 |
| Viatris Specialty LLC | 3 | $62 |
| Teva Pharmaceuticals USA, Inc. | 3 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| Boston Scientific | 1 | $27 |
| Inogen, Inc. | 2 | $26 |
| Azurity Pharmaceuticals, Inc. | 1 | $24 |
| La Jolla Pharmaceutical Company | 1 | $20 |
| Lilly USA, LLC | 1 | $18 |
| Astellas Pharma US Inc | 1 | $18 |
| Biohaven Pharmaceuticals, Inc. | 1 | $16 |
| Philips North America LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,234 in reported general payments places this provider in the 95th percentile of 1,246 physician assistant providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 218 | $203,386 |
| Breo ElliptaFluticasone/Vilanterol | 31 | $20,031 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 19 | $14,503 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 13 | $10,938 |
| Spiriva RespimatTiotropium Bromide | 15 | $10,817 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 16 | $9,991 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 13 | $9,316 |
| Wixela InhubFluticasone Propion/Salmeterol | 35 | $3,865 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 20 | $3,142 |
| Roflumilast | 17 | $1,729 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 39 | $688 |
| Ventolin HfaAlbuterol Sulfate | 12 | $656 |
| Azithromycin | 46 | $399 |
| Doxycycline Hyclate | 21 | $180 |
| Methylprednisolone | 30 | $172 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $2,997 | $232,733262 claims |
| Boehringer IngelheimStiolto Respimat, Combivent Respimat, Spiriva Respimat | $978 | $36,25847 claims |
| AstraZenecaBreztri Aerosphere | $2,315 | $9,99116 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,246 physician assistant providers in Louisiana.
Other physician assistant in Shreveport
- Emily BergeronShreveport$17K
- Seth MillerShreveport$16K
- Cassie MillerShreveport$16K
- Cedric WillisShreveport$12K
- Megan JohnsonShreveport$12K
- Dustin HadleyShreveport$11K
- Shannon KoveleskieShreveport$9K
- Colleen ClineShreveport$8K
- Jennifer BrownShreveport$7K
- Andree BreauxShreveport$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.